Please enable JavaScript.
Coggle requires JavaScript to display documents.
Alzheimer's Disease (Clinical Manifestations (short-term memory loss,…
Alzheimer's Disease
Epidemioligy
2/3 females, 1/3 males in the United States
-
-
Pathophysiology
-
-
-
-
-
age, genetics, diseases, behaviors may influence reaction
amyloid beta and to the progression of the disease
-
-
Treatment
-
N-methyl-D-aspartate receptor antagonist - blocks glutamate activity, slows down disease progression
Patient monitoring - regular follow up, every 3 months
memory aids, maintaining unimpaired cognitive abilities, hygiene and health maintenance
Risk Factors
Aging, family history, ApoE4, Down Syndrome
-
-
-